Sam Siegfried is a trusted advisor on emerging healthcare technology matters, with a particular focus on data privacy and security, artificial intelligence (AI), clinical research, and complex technology transactions. He helps healthcare and life sciences companies navigate evolving regulations, maximize data-driven opportunities, and implement innovative technologies. He also conducts privacy and research diligence and negotiates transition services agreements for mergers and acquisitions, strategic investments, and joint ventures.

With extensive experience in key privacy frameworks, including the Health Insurance Portability and Accountability Act (HIPAA), the California Consumer Privacy Act (CCPA), Washington’s My Health My Data Act (MHMDA), the General Data Protection Regulation (GDPR), and other evolving US and global data protection frameworks, Sam provides critical data strategy guidance to digital health platforms, genomic sequencing providers, health systems, biotech firms, and other health and life sciences organizations.

As AI reshapes healthcare delivery and innovation, Sam works closely with AI developers and deployers on AI governance programs, generative AI use, and consumer protection risks. In the clinical research space, he advises on federal and state research regulations, research compliance program development, research informed consent, and Institutional Review Board (IRB) requirements.

Show More

Education
Loyola University Chicago School of Law, JD, cum laude, 2015
Loyola University Chicago, BA, cum laude, 2012

Admissions
Illinois